Extracellular vesicles are membrane-bound nanoscale particles released by cells into their surrounding environment. They include exosomes, microvesicles, apoptotic bodies, and other vesicle populations that carry proteins, lipids, nucleic acids, and metabolites between cells. In nanomedicine and biotechnology, extracellular vesicles are studied as natural communication systems, disease biomarkers, therapeutic agents, and delivery vehicles.
Extracellular vesicles matter because they connect nanoscale transport with biology, diagnostics, and therapy. Their cargo can reflect cancer, inflammation, infection, neurodegeneration, and tissue injury, making them important for liquid biopsy and biomarker discovery. Engineered vesicles are also explored for drug delivery, RNA delivery, immune modulation, and regenerative medicine. Challenges include classification, isolation, purity, heterogeneity, potency assays, storage, safety, and scalable production. The field connects closely to exosomes, nanomedicine, and drug delivery.
Conferences on extracellular vesicles appear in biotechnology, cell biology, nanomedicine, diagnostics, regenerative medicine, and pharmaceutical programs. Sessions often cover vesicle biology, analytical methods, clinical biomarkers, engineering, manufacturing, and therapeutic development. Tracking extracellular-vesicle events helps researchers follow a field where natural nanoscale carriers are becoming important tools for precision medicine.